{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:43:50Z","timestamp":1771922630260,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00259-014-2759-x","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T02:31:18Z","timestamp":1395714678000},"page":"1673-1682","source":"Crossref","is-referenced-by-count":57,"title":["A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging"],"prefix":"10.1007","volume":"41","author":[{"given":"Kenichi","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Yamashina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Momose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Kasama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark I.","family":"Travin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold F.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"2759_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2012.05.004","volume":"55","author":"AP Kalogeropoulos","year":"2012","unstructured":"Kalogeropoulos AP, Georgiopoulou VV, Butler J. Clinical adoption of prognostic biomarkers: the case for heart failure. Prog Cardiovasc Dis. 2012;55:3\u201313.","journal-title":"Prog Cardiovasc Dis"},{"key":"2759_CR2","first-page":"e147","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Drazner MH, et al. 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;62:e147\u2013239. doi: 10.1161\/CIR.0b013e31829e8776 .","journal-title":"Circulation"},{"key":"2759_CR3","first-page":"672","volume":"24","author":"M Nakajo","year":"1983","unstructured":"Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC, et al. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med. 1983;24:672\u201382.","journal-title":"J Nucl Med"},{"key":"2759_CR4","first-page":"471","volume":"33","author":"P Merlet","year":"1992","unstructured":"Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471\u20137.","journal-title":"J Nucl Med"},{"key":"2759_CR5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1071-3581(98)90112-X","volume":"5","author":"T Nakata","year":"1998","unstructured":"Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol. 1998;5:579\u201390.","journal-title":"J Nucl Cardiol"},{"key":"2759_CR6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jacc.2008.10.025","volume":"53","author":"S Tamaki","year":"2009","unstructured":"Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol. 2009;53:426\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"2759_CR7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","volume":"55","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"2759_CR8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","volume":"29","author":"HJ Verberne","year":"2008","unstructured":"Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147\u201359.","journal-title":"Eur Heart J"},{"key":"2759_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12149-010-0452-0","volume":"25","author":"Y Kuwabara","year":"2011","unstructured":"Kuwabara Y, Tamaki N, Nakata T, Yamashina S, Yamazaki J. Determination of the survival rate in patients with congestive heart failure stratified by 123I-MIBG imaging: a meta-analysis from the studies performed in Japan. Ann Nucl Med. 2011;25:101\u20137.","journal-title":"Ann Nucl Med"},{"key":"2759_CR10","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424\u201333.","journal-title":"Circulation"},{"key":"2759_CR11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.amjcard.2010.12.019","volume":"107","author":"Y Kuramoto","year":"2011","unstructured":"Kuramoto Y, Yamada T, Tamaki S, Okuyama Y, Morita T, Furukawa Y, et al. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol. 2011;107:1185\u201390.","journal-title":"Am J Cardiol"},{"key":"2759_CR12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12350-012-9603-0","volume":"19","author":"ES Ketchum","year":"2012","unstructured":"Ketchum ES, Jacobson AF, Caldwell JH, Senior R, Cerqueira MD, Thomas GS, et al. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol. 2012;19:1007\u201316.","journal-title":"J Nucl Cardiol"},{"key":"2759_CR13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcmg.2013.02.007","volume":"6","author":"T Nakata","year":"2013","unstructured":"Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of 123I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6:772\u201384.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2759_CR14","first-page":"1757","volume":"42","author":"T Wakabayashi","year":"2001","unstructured":"Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med. 2001;42:1757\u201367.","journal-title":"J Nucl Med"},{"key":"2759_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0735-1097(02)02700-6","volume":"41","author":"T Yamada","year":"2003","unstructured":"Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol. 2003;41:231\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"2759_CR16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mhj.2001.112783","volume":"141","author":"J Yamazaki","year":"2001","unstructured":"Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy \u2013 Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J. 2001;141:645\u201352.","journal-title":"Am Heart J"},{"key":"2759_CR17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00006231-199906000-00007","volume":"20","author":"M Momose","year":"1999","unstructured":"Momose M, Kobayashi H, Iguchi N, Matsuda N, Sakomura Y, Kasanuki H, et al. Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. Nucl Med Commun. 1999;20:529\u201335.","journal-title":"Nucl Med Commun"},{"key":"2759_CR18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1253\/circj.66.537","volume":"66","author":"T Matsui","year":"2002","unstructured":"Matsui T, Tsutamoto T, Maeda K, Kusukawa J, Kinoshita M. Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments \u2013 comparison with neurohumoral factors. Circ J. 2002;66:537\u201343.","journal-title":"Circ J"},{"key":"2759_CR19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2967\/jnumed.107.047548","volume":"49","author":"S Kasama","year":"2008","unstructured":"Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N, Sato Y, et al. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction. J Nucl Med. 2008;49:907\u201314.","journal-title":"J Nucl Med"},{"key":"2759_CR20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","volume":"116","author":"D Mozaffarian","year":"2007","unstructured":"Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, et al. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation. 2007;116:392\u20138.","journal-title":"Circulation"},{"key":"2759_CR21","doi-asserted-by":"crossref","first-page":"e001015","DOI":"10.1136\/bmjopen-2012-001015","volume":"2","author":"T Doi","year":"2012","unstructured":"Doi T, Nakata T, Hashimoto A, Yuda S, Wakabayashi T, Kouzu H, et al. Synergistic prognostic values of cardiac sympathetic innervation with left ventricular hypertrophy and left atrial size in heart failure patients without reduced left ventricular ejection fraction: a cohort study. BMJ Open. 2012;2:e001015.","journal-title":"BMJ Open"},{"key":"2759_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12350-011-9468-7","volume":"19","author":"LJ Shaw","year":"2012","unstructured":"Shaw LJ, Min JK, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT. J Nucl Cardiol. 2012;19:43\u201352.","journal-title":"J Nucl Cardiol"},{"key":"2759_CR23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1253\/circj.CJ-11-0857","volume":"76","author":"K Nakajima","year":"2012","unstructured":"Nakajima K, Matsuo S, Okuyama C, Hatta T, Tsukamoto K, Nishimura S, et al. Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease. Circ J. 2012;76:168\u201375.","journal-title":"Circ J"},{"key":"2759_CR24","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"AJ Moss","year":"1996","unstructured":"Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933\u201340.","journal-title":"N Engl J Med"},{"key":"2759_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2967\/jnumed.107.042564","volume":"49","author":"D Nagahara","year":"2008","unstructured":"Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M, Noda R, et al. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med. 2008;49:225\u201333.","journal-title":"J Nucl Med"},{"key":"2759_CR26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2967\/jnumed.110.074971","volume":"51","author":"K Nishisato","year":"2010","unstructured":"Nishisato K, Hashimoto A, Nakata T, Doi T, Yamamoto H, Nagahara D, et al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs. J Nucl Med. 2010;51:1241\u20139.","journal-title":"J Nucl Med"},{"key":"2759_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00259-011-1963-1","volume":"39","author":"K Nakajima","year":"2012","unstructured":"Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging. 2012;39:113\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2759_CR28","doi-asserted-by":"crossref","unstructured":"Kelesidis I, Travin MI. Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death. J Nucl Cardiol. 2012;19:142\u201352. quiz 153\u20137.","DOI":"10.1007\/s12350-011-9482-9"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-014-2759-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2759-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:29:51Z","timestamp":1565299791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-014-2759-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2759"],"URL":"https:\/\/doi.org\/10.1007\/s00259-014-2759-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}